Performance

FTH -51.70%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
FTH	-42.49%	-51.70%*	-51.70%*	—	-69.23%*	-0.18*	0.00%*

Summary

FTH at a glance

FTH returned -51.70% since Feb 18, 2026. Its worst drop since then was -69.23%, smaller than 6% of stocks on Redstone, and its Sharpe ratio of -0.18 beats 20% of stocks on Redstone. It hasn't paid a dividend since it listed.

Ranking

How FTH ranks

Dividend Yield Rank *

Current Drawdown

-68.34%

Rolling Volatility

176.07%

Actions

Metrics

Risk Indicators*

Alpha-32.59%

Beta0.94x

Sharpe-0.18

Sortino-0.25

Omega0.97

Calmar-0.75

Martin-0.69

Profile

About FTH

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $328M
Listed: Feb 2021
Employees: 29
Headquarters: Austin, TX
Website: faeththerapeutics.com

Comparisons

FTH: Faeth Therapeutics, Inc.

FTH at a glance

How FTH ranks

Current Drawdown

Rolling Volatility

About FTH

Related comparisons